This Pharma Company Stays Innovative by Doing Two Things
Harvard Business Review
MARCH 14, 2017
When one of us (Vivek) and his team launched Roivant Sciences in 2014 and began developing treatments for Alzheimer’s disease — they were determined to learn from the pharma industry’s innovation issues and build a more sustainable innovation engine. Food and Drug Administration (FDA), the lowest number since 2007.
Let's personalize your content